Showing results (381-390 of 525) with videos related to

Sort By:
Pageof 53
Clinical Immunology and Immunopathology|January 1, 1984
Lack of IgG in a healthy adult: a rare case of dysgammaglobulinemia with undetectable serum IgG, IgA2, and IgEL Hammarström, G Holm, J Palmblad, et al.
Scandinavian Journal of Immunology|February 1, 1989
Recombinant protein A of non-staphylococcal origin is not mitogenic for human peripheral lymphocytes. Mitogenicity of natural protein A is caused by a contaminantU Persson, M Inganäs, C I Smith, et al.
Leukemia|February 1, 1989
Clonal immunoglobulin gene rearrangements in primary mediastinal clear cell lymphomasL B Brandter, C I Smith, L Hammarström, et al.
American Journal of Medical Genetics|June 26, 2001
Microphthalmia, facial anomalies, microcephaly, thumb and hallux hypoplasia, and agammaglobulinemiaA Verloes, M F Dresse, H Keutgen, et al.
International Immunology|November 1, 1991
TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytesK B Islam, L Nilsson, P Sideras, et al.
Experimental and Clinical Immunogenetics|January 1, 1991
C4 polymorphism and major histocompatibility complex haplotypes in IgA deficiency: association with C4A null haplotypesD Bućin, L Truedsson, L Hammarström, et al.
Clinical and Experimental Immunology|September 1, 1988
Subclass distribution and IgE responses after treatment in human schistosomiasisB Evengård, L Hammarström, C I Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Molecular and serologic analysis of IgG1 deficiency caused by new forms of the constant region of the Ig H chain gene deletionsC I Smith, L Hammarström, J I Henter, et al.
Circulation|July 7, 1999
Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled studyH A Valantine, S Z Gao, S G Menon, et al.
The New England Journal of Medicine|October 10, 1996
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study TeamD A Katzenstein, S M Hammer, M D Hughes, et al.
Pageof 53